These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26292297)

  • 1. Clonal Diversification and Changes in Lipid Traits and Colony Morphology in Mycobacterium abscessus Clinical Isolates.
    Park IK; Hsu AP; Tettelin H; Shallom SJ; Drake SK; Ding L; Wu UI; Adamo N; Prevots DR; Olivier KN; Holland SM; Sampaio EP; Zelazny AM
    J Clin Microbiol; 2015 Nov; 53(11):3438-47. PubMed ID: 26292297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Mycobacterium abscessus Subspecies According to Whole-Genome Sequencing.
    Luo L; Liu W; Li B; Li M; Huang D; Jing L; Chen H; Yang J; Yue J; Wang F; Chu H; Zhang Z
    J Clin Microbiol; 2016 Dec; 54(12):2982-2989. PubMed ID: 27682129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and characterization of the genetic changes responsible for the characteristic smooth-to-rough morphotype alterations of clinically persistent Mycobacterium abscessus.
    Pawlik A; Garnier G; Orgeur M; Tong P; Lohan A; Le Chevalier F; Sapriel G; Roux AL; Conlon K; Honoré N; Dillies MA; Ma L; Bouchier C; Coppée JY; Gaillard JL; Gordon SV; Loftus B; Brosch R; Herrmann JL
    Mol Microbiol; 2013 Nov; 90(3):612-29. PubMed ID: 23998761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of the MALDI-TOF MS method to identify nontuberculous mycobacteria.
    Kodana M; Tarumoto N; Kawamura T; Saito T; Ohno H; Maesaki S; Ikebuchi K
    J Infect Chemother; 2016 Jan; 22(1):32-5. PubMed ID: 26603481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycopeptidolipid Genotype Correlates With the Severity of Mycobacterium abscessus Lung Disease.
    Li B; Ye M; Zhao L; Guo Q; Chen J; Xu B; Zhan M; Zhang Y; Zhang Z; Chu H
    J Infect Dis; 2020 Mar; 221(Suppl 2):S257-S262. PubMed ID: 32176786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Nontuberculous Mycobacteria from Clinical Isolates.
    Rodríguez-Sánchez B; Ruiz-Serrano MJ; Marín M; López Roa P; Rodríguez-Créixems M; Bouza E
    J Clin Microbiol; 2015 Aug; 53(8):2737-40. PubMed ID: 26063855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Nontuberculous Mycobacteria in French Polynesia.
    Phelippeau M; Osman DA; Musso D; Drancourt M
    J Clin Microbiol; 2015 Dec; 53(12):3798-804. PubMed ID: 26400787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Isogenic Strains Shows No Evidence of Altered Nosocomial Transmission-Competency of Rough, GPL-Negative Mycobacterium abscessus Strains.
    Meir M; Foreman M; Bar-Oz M; Naor N; Rozenblit A; Barkan D
    Microbiol Spectr; 2022 Apr; 10(2):e0199021. PubMed ID: 35311553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species spectrum of nontuberculous mycobacteria isolated from suspected tuberculosis patients, identification by multi locus sequence analysis.
    Hashemi-Shahraki A; Bostanabad SZ; Heidarieh P; Titov LP; Khosravi AD; Sheikhi N; Ghalami M; Nojoumi SA
    Infect Genet Evol; 2013 Dec; 20():312-24. PubMed ID: 24070831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of nontuberculous mycobacteria in MGIT by matrix-assisted laser desorption/ionization mass spectrometry.
    Chien JY; Yu CJ; Hsueh PR
    Future Microbiol; 2016 Aug; 11():1025-33. PubMed ID: 27502041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogenomics of Brazilian epidemic isolates of Mycobacterium abscessus subsp. bolletii reveals relationships of global outbreak strains.
    Davidson RM; Hasan NA; de Moura VC; Duarte RS; Jackson M; Strong M
    Infect Genet Evol; 2013 Dec; 20():292-7. PubMed ID: 24055961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular epidemiology of Mycobacterium abscessus complex isolates in Ireland.
    O'Driscoll C; Konjek J; Heym B; Fitzgibbon MM; Plant BJ; Ní Chróinín M; Mullane D; Lynch-Healy M; Corcoran GD; Schaffer K; Rogers TR; Prentice MB
    J Cyst Fibros; 2016 Mar; 15(2):179-85. PubMed ID: 26072272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomics of glycopeptidolipid biosynthesis in Mycobacterium abscessus and M. chelonae.
    Ripoll F; Deshayes C; Pasek S; Laval F; Beretti JL; Biet F; Risler JL; Daffé M; Etienne G; Gaillard JL; Reyrat JM
    BMC Genomics; 2007 May; 8():114. PubMed ID: 17490474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of methods for the isolation of nontuberculous mycobacteria from patients with cystic fibrosis, bronchiectasis and patients assessed for lung transplantation.
    Stephenson D; Perry A; Appleby MR; Lee D; Davison J; Johnston A; Jones AL; Nelson A; Bourke SJ; Thomas MF; De Soyza A; Lordan JL; Lumb J; Robb AE; Samuel JR; Walton KE; Perry JD
    BMC Pulm Med; 2019 Jan; 19(1):19. PubMed ID: 30665395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of MALDI-TOF MS for Identification of Nontuberculous Mycobacterium Species Isolated from Clinical Specimens.
    Mediavilla-Gradolph MC; De Toro-Peinado I; Bermúdez-Ruiz MP; García-Martínez Mde L; Ortega-Torres M; Montiel Quezel-Guerraz N; Palop-Borrás B
    Biomed Res Int; 2015; 2015():854078. PubMed ID: 26106617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MALDI-TOF mass spectrometry from nucleic acid: development and evaluation of a novel platform for identification of mycobacteria and detection of genetic markers of resistance.
    DeCurtis EK; Machado I; Kuss-Duerkop SK; Wang Y; Khare R
    Microbiol Spectr; 2024 Oct; 12(10):e0163824. PubMed ID: 39189753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Mycobacterium abscessus Subspecies by MALDI-TOF Mass Spectrometry and Machine Learning.
    Rodríguez-Temporal D; Herrera L; Alcaide F; Domingo D; Héry-Arnaud G; van Ingen J; Van den Bossche A; Ingebretsen A; Beauruelle C; Terschlüsen E; Boarbi S; Vila N; Arroyo MJ; Méndez G; Muñoz P; Mancera L; Ruiz-Serrano MJ; Rodríguez-Sánchez B
    J Clin Microbiol; 2023 Jan; 61(1):e0111022. PubMed ID: 36602341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.
    Roux AL; Catherinot E; Soismier N; Heym B; Bellis G; Lemonnier L; Chiron R; Fauroux B; Le Bourgeois M; Munck A; Pin I; Sermet I; Gutierrez C; Véziris N; Jarlier V; Cambau E; Herrmann JL; Guillemot D; Gaillard JL;
    J Cyst Fibros; 2015 Jan; 14(1):63-9. PubMed ID: 25085077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of rpoB sequence analysis in the differentiation of Mycobacterium abscessus and Mycobacterium chelonae: a critical judgement in cystic fibrosis?
    Arnold C; Barrett A; Cross L; Magee JG
    Clin Microbiol Infect; 2012 May; 18(5):E131-3. PubMed ID: 22429487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phagocytosis and cytokine response to rough and smooth colony variants of Mycobacterium abscessus by human peripheral blood mononuclear cells.
    Jönsson B; Ridell M; Wold AE
    APMIS; 2013 Jan; 121(1):45-55. PubMed ID: 23030647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.